Dyne Therapeutics is dedicated to improving the lives of individuals with genetically driven neuromuscular diseases by developing therapeutics targeting muscle and the central nervous system. The company advances clinical programs for myotonic dystrophy type 1 (DM1) and Duchenne muscular dystrophy (DMD), while also pursuing preclinical research for facioscapulohumeral muscular dystrophy (FSHD) and Pompe disease. Dyne's mission is to deliver functional improvement, making a significant impact on affected individuals, families, and communities.
Dyne Therapeutics is seeking a Clinical Trial Manager to ensure the successful execution of clinical strategies within the company's clinical programs for DM1 and DMD. This role involves managing CROs, overseeing studies, ensuring regulatory compliance, and collaborating with internal teams to deliver high-quality clinical trials. The position is based in Waltham, MA.
Dyne Therapeutics is dedicated to improving the lives of individuals with genetically driven neuromuscular diseases by developing therapeutics targeting muscle and the central nervous system. The company advances clinical programs for myotonic dystrophy type 1 (DM1) and Duchenne muscular dystrophy (DMD), while also pursuing preclinical research for facioscapulohumeral muscular dystrophy (FSHD) and Pompe disease. Dyne's mission is to deliver functional improvement, making a significant impact on affected individuals, families, and communities.
Mount Sinai